High Throughput Process Development Market by Type (Tools & Systems, Consumables, Software and Solutions & Services)
Industry: Healthcare
Published Date: March-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 259
Report ID: PMRREP31236
The global revenue from the High Throughput Process Development Market was around US$ 9.1 Billion in 2022, with the global market expected to grow at a CAGR of 8.7% to reach a valuation of around US$ 22.8 Billion by the end of 2033.
|
Market Size (2023) |
US$ 9.95 Billion |
|
Projected Market Value (2033) |
US$ 22.8 Billion |
|
Global Market Growth Rate (2023 to 2033) |
8.7% CAGR |
|
Market Share of Top 5 Countries |
60.8.7% |
As assessed by Persistence Market Research, tools and systems held a market share of around 51.94% in the global market, in 2022. Overall, high throughput process development market sales account for around 7.2% of revenue share in the global life science market, which was valued at around US$ 127.2 Billion in 2022.
The global market recorded a historic CAGR of 9.8% in the last 8 years from 2014 to 2022.
High-throughput process development (HTPD) shortens the time while expanding the data's accessibility for quality-by-design methodologies. Chromatography techniques used by HTPD enable somewhat more precise result analysis and prediction. High throughput progressive development tackles concerns about decreasing development time and enhancing the performance of the end product by utilising a knowledge base. Furthermore, it is projected that high throughput computing, which groups several servers to do a single computational task, would develop into a crucial field of activity. High throughput cell biology is also utilised to answer biological questions that can't be answered by more traditional methods.
Product, application, process development are the categories under which the global high throughput process development is categorised. It offers a systematic strategy for the creation of time- and resource-based chromatographic technologies by combining miniaturisation, automation, and parallel processing. Numerous researchers created non-chromatographic separations like two-phase aqueous systems as well as chromatography steps for purification using high-throughput methods.
The global market is likely to show high growth over the coming years at a CAGR of 8.7% and reach a global market size of US$ 22.8 Billion by 2033.
“Utilizing Miniature Bioreactors to Develop High-Throughput Processes”
Miniaturized bioreactor use and commercialization are on the rise in the market for high throughput process development. In the life science sector, these bioreactors have taken the place of conventional bioreactor systems. Conventional bioreactor systems have some drawbacks and require a lot of time and resources. Thus, the development of disposable, miniature bioreactors and micro platforms increases demand for these tools for the development and testing of novel pharmaceutical products.
High throughput miniaturised bioreactor systems shorten the time needed to create cell culture processes, expediting the development of biopharmaceuticals.
The application fields for biotechnology tools are growing as a result of ongoing research and development in the sector, which is pushing the introduction of novel and ground-breaking technologies. Technological and procedural advancements, along with the expansion of application areas they cause, are expected to produce a number of job chances and, as a result, an increase in the wage structure of the relevant workforce. The focus of corporations and organizations on the growth of the biotechnology industry in their various jurisdictions is a result of this attracting the attention of governments in several countries, especially emerging economies.
To support the bioscience sector in the United States, the state governments run a number of initiatives, including the Connecticut Small Business Innovation and Diversification Program, Florida High Tech Corridor Phase II SBIR/STTR External Investment, Hawaii Small Business Center, Indiana 21st Century Research and Technology Fund, Kansas Bioscience Matching Fund, and Michigan Emerging Technologies Fund.
Various state government initiatives available in the US attempt to finance small company innovation research (SBIR). Additionally, the Biotechnology Industry Organization (BIO), U.S., encourages collaborations among business stakeholders, academic institutions, and state governments to create bioscience clusters.
“Better, More Relevant Models For The Industry Are Needed.”
The future of high throughput process development is expected to be impacted by the difficulties and limitations that high throughput process development in the bio manufacturing industry faces. Better industry-relevant models are advocated for by businesses like GE Healthcare, Sartorius AG, and Thermo Fischer to enhance the bio manufacturing process.
The problems of applying industry models, whether computerised or scaled-down versions, are significant limiting factors at the commercial manufacturing scale of the product. In the development of high throughput processes, estimation of the equivalent column volume and the adsorption isotherm model parameters becomes difficult, and the inconsistent data is highly problematic.
In the column experiments, this results in inaccurate predictions. Furthermore, more accurate mechanistic models are now necessary for the right process development due to the strict regulatory requirements for the Quality by Design approach used in the bio manufacturing process.
Another significant issue that could limit market expansion is a lack of qualified specialists. There are only a few skilled medical professionals accessible to conduct the several parallel cultivations during the bio production process. As a result, the market for high throughput process development is anticipated to be constrained by a lack of competent individuals at academic and research institutions and a decline in the number of CROs in developing countries.
Why is the United States Market Booming?
“Presence of Leading Key Players”
The United States accounted for around 93.28% market share in the North America market in 2022. The regional dominance is attributed to the existing biopharmaceutical industry.
The demand for high throughput product development is anticipated to increase with the CRO's growth.
Additionally, the presence of numerous competitors in the area and the availability of scientists and experts to conduct ongoing research are anticipated to propel the market for high throughput process development.
Because the life sciences sector is well-established in North America, different analytical and single-use bioreactors utilised in high throughput processes are adopted more quickly. This is anticipated to accelerate market expansion in the region.
Will the United Kingdom Be a Lucrative Market for High Throughput Process Development?
“Software Services and The Rise of Automation”
The United Kingdom market held around 14.01% market share of the Europe market in 2022. The market in the region is being driven by the expansion of contract research organisations and the existence of several suppliers of laboratory stainless steel, single-use bioreactors and analytical equipment.
In addition, a summit on bioprocessing encourages involvement in and knowledge of various approaches to the development of high throughput processes.
A software platform for high throughput process development is likely to be created in the region as a result of the advent of automation and software services.
Therefore, technical advancements and the expanding biopharmaceutical and research industries are projected to present a wealth of chances for advancing high throughput process development.
How is China Emerging as a Prominent Market?
“Number of Advanced Process Development Approaches”
China held a market share of about 40.9% of the East Asia market in 2022. The market for high process development in Chinais anticipated to increase as a result of expanding R&D and the emergence of numerous important players in the area.
Because of its widespread use and approval by companies and researchers, the market for single-use devices is at its pinnacle. Research and development activities are driven by the expanding biopharmaceutical sector in the region in order to meet the market's unmet clinical demands. The demand for high throughput process development is further increased by the use of various high process development methodologies, such as scale up studies and process optimization.
The market for high throughput process development is projected to have slow expansion due to low awareness and weaker investment support in several emerging markets.
Which Product is Driving Demand within the Global Market?
“Growing Advantages of Tools & Systems”
The tools & systems segment held around 51.9% share of the total market in 2022. For the creation of high throughput processes, companies have access to and use tools and systems like manual, automated, analytical, and high throughput bioreactor systems.
Bioprocessing involves the use of shake flasks, liquid handling platforms, gas chromatography systems, mini/micro bioreactors, bench top bioreactors, high-performance liquid chromatography, and ultra-performance liquid chromatography. Since many bioreactors are single-use and reusable, they are effective in reducing costs while simultaneously providing high-quality product purification.
Which Application is Widely Adopted for the Production of High Throughput Process Development?
“Growing Adoption of Micro And Mini Reactors”
Mammalian cell culture held around 56.3% share of the total market in 2022. Recent technology developments have made it possible to use high-throughput techniques to a wider range of traditionally labor-intensive biopharmaceutical manufacturing process development tasks.
Numerous industry providers offer wide range of mini and micro-reactor formats for the improvement of cell culture and fermentation, as well as plate- and micro-column-based products for the development of purification processes and robotic liquid handling systems.
These techniques enable the gathering and analysis of very huge data sets due to the ever-increasing computational capacity of modern systems. Companies may conduct more tests and obtain a deeper comprehension of the manufacturing process sooner in the product development phase due to high-throughput process development and data analysis. This new tendency is in line with rising regulatory standards as well as the concepts of Quality by Design, which are increasingly being used in the creation of biopharmaceuticals.
Which Process Development is Driving Demand within the Global Market?
“Number of Procedure Involved in Upstream Process”
The upstream segment held around 36.9% share of the total market in 2022. The bioprocessing stage, which entails producing cell lines at a greater scale, is referred to as the upstream process in the creation of high throughput processes.
The term "upstream process" refers to the first step in the growth of bacterial and mammalian cell lines in cell culture. This procedure involves a number of processes, including the formation of an inoculum, the creation of a media, the use of genetic engineering, and the optimization and proliferation of cells. Whereas, downstream process developments include purification of cell line development only. This factor is responsible for segment growth.
Which End User Propels the Global Sales in the Market?
“Technological Development”
The biopharmaceuticals segment held a share of about 48.2% in 2022, within the global market. This is related to a rise in R&D expenditures and activity by companies as well as the growing necessity to find new pharmacological targets. Introduction of sophisticated platforms for high throughput process development, technological developments in drug development arena, and an increase in strategic progresses made by market player are additional important factors boosting the segment's growth.
Development and launch of novel product lines and geography expansion are the key strategies adopted by key players within this market arena.
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the high throughput process development market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2014 to 2022 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Application:
Process Development:
End User:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at around US$ 9.1 Billion in 2022.
The global market is estimated to reach around US$ 9.95 Billion in 2023.
The global market is set to reach valuation of US$ 22.8 Billion by the end of 2033.
Sales of the market are set to witness growth at a CAGR of 8.7% between 2023 and 2033.
Demand for the global market increased at a 9.8% CAGR from 2014 to 2022.
The U.S., Japan, China, Germany, and France account for most demand within the market, currently holding around 60.9% market share.
The U.S. accounts for around 93.28% share of the North American market in 2022.
The China market held a share of about 40.9% in the East Asia High throughput process development market in 2022.
The U.K. market held around 14.01% market share of the Europe market in 2022.
GE Healthcare, Merck KgaA, Danaher Corporation, Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Sartorius AG, Agilent Technologies, Luminex Applikon, Tecan Trading AG, Eppendorf AG and PerkinElmer Inc. are the key players active within this market space.
